MX344494B - Inmunogeno y antiveneno contra el veneno de la araña violinista. - Google Patents

Inmunogeno y antiveneno contra el veneno de la araña violinista.

Info

Publication number
MX344494B
MX344494B MX2011012895A MX2011012895A MX344494B MX 344494 B MX344494 B MX 344494B MX 2011012895 A MX2011012895 A MX 2011012895A MX 2011012895 A MX2011012895 A MX 2011012895A MX 344494 B MX344494 B MX 344494B
Authority
MX
Mexico
Prior art keywords
sphingomyelinases
expression
immunogen
loxosceles
fragments
Prior art date
Application number
MX2011012895A
Other languages
English (en)
Inventor
Alagon Cano Alejandro
Pablo Stock Silberman Roberto
Margarita Ramos Cerrillo Blanca
Olvera Rodriguez Alejandro
Sanchez-Lopez Rosana
Original Assignee
Univ Nac Autónoma De México
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nac Autónoma De México filed Critical Univ Nac Autónoma De México
Publication of MX344494B publication Critical patent/MX344494B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Insects & Arthropods (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La presente invención se refiere a el asilamiento caracterización y expresión de los fragmentos de DNA codificantes de las esfingomielinasas D de 3 especies de araña del género Loxosceles: L. boneti, L. reclusa y L. laeta y sus toxoides. También comprende la producción por medios recombinantes de las esfingomielinasas D activas y sus toxoides su uso como inmunógeno para la producción en vertebrados de anticurpos neutralizantes del veneno correspondiente y de los fragmentos F(ab')2 respectivos. También se incluye el uso de las esfingomielinasas D recomnbinantes como parte de un matriz antigénica útil en la inmunopurificación de anticuerpos y sus fragmentos o como parte de algún dispositivo diagnóstico para corroborar en clínica que el agente causal del estado de envenenamiento de un paciente sea una araña del género Loxosceles. Así mismo, la invención incluye los vectores moleculares para la expresión de los fragmentos de DNA, las cepas que los comprenden, capaces de expresar las SMD de Loxosceles y los métodos para su expresión.
MX2011012895A 2004-08-31 2005-08-29 Inmunogeno y antiveneno contra el veneno de la araña violinista. MX344494B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXPA04008435A MXPA04008435A (es) 2004-08-31 2004-08-31 Inmunogeno y anti-veneno contra el veneno de la arana violinista.
PCT/MX2005/000071 WO2006025718A2 (es) 2004-08-31 2005-08-29 Inmunógeno y antiveneno contra el veneno de la araña violinista

Publications (1)

Publication Number Publication Date
MX344494B true MX344494B (es) 2016-12-19

Family

ID=36000447

Family Applications (2)

Application Number Title Priority Date Filing Date
MXPA04008435A MXPA04008435A (es) 2004-08-31 2004-08-31 Inmunogeno y anti-veneno contra el veneno de la arana violinista.
MX2011012895A MX344494B (es) 2004-08-31 2005-08-29 Inmunogeno y antiveneno contra el veneno de la araña violinista.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MXPA04008435A MXPA04008435A (es) 2004-08-31 2004-08-31 Inmunogeno y anti-veneno contra el veneno de la arana violinista.

Country Status (6)

Country Link
US (2) US8287860B2 (es)
AR (1) AR055482A1 (es)
AU (1) AU2005280742B2 (es)
BR (1) BRPI0514809A (es)
MX (2) MXPA04008435A (es)
WO (1) WO2006025718A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008435A (es) * 2004-08-31 2006-03-02 Univ Mexico Nacional Autonoma Inmunogeno y anti-veneno contra el veneno de la arana violinista.
MX367136B (es) 2012-10-18 2019-08-06 Inosan Biopharma S A Star Proceso para purificar fragmentos de anticuerpos polivalentes derivados de plasma hiperinmune.
IT202000023809A1 (it) * 2020-10-09 2022-04-09 Craniomed Group S R L Anatossine e anticorpi per l’uso nella prevenzione e nel trattamento della malattia da coronavirus.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196193A (en) 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms
MXPA99011191A (es) 1999-12-03 2005-04-04 Univ Mexico Nacional Autonoma Inmunogeno, anti-veneno y vacuna contra el venenode la arana viuda negra.
MXPA04008435A (es) * 2004-08-31 2006-03-02 Univ Mexico Nacional Autonoma Inmunogeno y anti-veneno contra el veneno de la arana violinista.

Also Published As

Publication number Publication date
MXPA04008435A (es) 2006-03-02
US8287860B2 (en) 2012-10-16
AU2005280742A1 (en) 2006-03-09
AU2005280742B2 (en) 2013-01-17
US20110177078A1 (en) 2011-07-21
AR055482A1 (es) 2007-08-22
US20130071399A1 (en) 2013-03-21
WO2006025718A3 (es) 2006-11-02
WO2006025718A2 (es) 2006-03-09
US8541551B2 (en) 2013-09-24
BRPI0514809A (pt) 2008-06-24

Similar Documents

Publication Publication Date Title
NZ600584A (en) Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof
EP2292645A3 (en) Small Streptococcus pyogenes antigens and their use
MX2011003502A (es) Anticuerpo de cadena sencilla biespecifica de psmaxcd3 especifico a traves de especies.
HK1113393A1 (en) Secretion of antibodies without signal peptides from bacteria
NZ599193A (en) Siglec 15 antibodies in treating bone loss-related disease
CY1109715T1 (el) IL-1β ΔΕΣΜΕΥΤΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΚΑΙ ΘΡΑΥΣΜΑΤΑ ΑΥΤΩΝ
TW200510459A (en) RG1 antibodies and uses thereof
WO2004006952A3 (en) Therapeutic tuberculosis vaccines
IN2009CN03372A (es)
MX344494B (es) Inmunogeno y antiveneno contra el veneno de la araña violinista.
DE602005012530D1 (de) Immunogene glykopeptide zur diagnose von infektionen pathogener mikroorganismen
WO2008084072A3 (en) Protective proteins of s. agalactiae, combinations thereof and methods of using the same
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
WO2008010098A3 (en) Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
ATE415629T1 (de) In-vitro-diagnoseverfahren und kit für eine schwarzschimmel-infektion
WO2006138449A3 (en) Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen
GB0706558D0 (en) Diagnostic assay
MX2009008754A (es) Anticuerpos novedosos contra igf-1r.
ATE456659T1 (de) Streptococcus pyogenes polypeptide und entsprechende dna fragmente
ATE532065T1 (de) Antigenziele der autoimmunbedingten schallempfindungsschwerhörigkeit (aisnhl) und entwicklung von tests zur diagnose und behandlung von aisnhl
SG156619A1 (en) Novel cancer associated antibodies and antigens and their use in cancer diagnosis
WO2005065711A3 (en) Mammalian receptor proteins; related reagents and methods
PH12019500431A1 (en) Neutralizing anti-tetanus human monoclonal antibodies for c. tetani infection, method of obtaining said monoclonal antibodies and their use in immunotherapy for accidents susceptible to tetanus bacillus infection
WO2005077412A3 (en) Compositions and methods of use of w-peptides
AU2003288711A1 (en) Polypeptides for the diagnosis and therapy of leishmaniasis